New global guidelines warn against obesity drugs for children under 10

• WHO recommends against pharmacological treatment for obesity in children under 10 years, emphasizing lifestyle interventions including diet and exercise as first-line management
• Weight-loss medications such as GLP-1 receptor agonists should not be routinely used in this age group due to insufficient evidence on long-term safety and efficacy
• Clinical practice should prioritize family-based behavioural approaches and environmental modifications to address childhood obesity in under-10s

Care should focus on healthy eating and exercise, not medicines such as weight-loss injections, says the World Health Organization

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.